Regenxbio Inc (RGNX)
16.64
+0.44
(+2.72%)
USD |
NASDAQ |
May 02, 16:00
16.63
-0.01
(-0.06%)
Pre-Market: 20:00
Regenxbio 1 Year Total Returns (Daily): -14.62% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -14.62% |
May 01, 2024 | -19.40% |
April 30, 2024 | -20.71% |
April 29, 2024 | -17.10% |
April 26, 2024 | -12.01% |
April 25, 2024 | -15.12% |
April 24, 2024 | -16.28% |
April 23, 2024 | -16.62% |
April 22, 2024 | -17.99% |
April 19, 2024 | -18.24% |
April 18, 2024 | -14.72% |
April 17, 2024 | -11.99% |
April 16, 2024 | -7.70% |
April 15, 2024 | -4.96% |
April 12, 2024 | 2.09% |
April 11, 2024 | 7.40% |
April 10, 2024 | 9.21% |
April 09, 2024 | 2.92% |
April 08, 2024 | 3.90% |
April 05, 2024 | 5.50% |
April 04, 2024 | 0.16% |
April 03, 2024 | 4.49% |
April 02, 2024 | 7.30% |
April 01, 2024 | 13.86% |
March 28, 2024 | 11.90% |
Date | Value |
---|---|
March 27, 2024 | 14.57% |
March 26, 2024 | 9.39% |
March 25, 2024 | 8.99% |
March 22, 2024 | 10.61% |
March 21, 2024 | 7.55% |
March 20, 2024 | 7.81% |
March 19, 2024 | 11.23% |
March 18, 2024 | 10.93% |
March 15, 2024 | 6.63% |
March 14, 2024 | 3.90% |
March 13, 2024 | 8.13% |
March 12, 2024 | 6.70% |
March 11, 2024 | 10.92% |
March 08, 2024 | -0.96% |
March 07, 2024 | -0.90% |
March 06, 2024 | 4.67% |
March 05, 2024 | 0.90% |
March 04, 2024 | -12.42% |
March 01, 2024 | -12.22% |
February 29, 2024 | -21.62% |
February 28, 2024 | -10.56% |
February 27, 2024 | -8.75% |
February 26, 2024 | -13.94% |
February 23, 2024 | -19.77% |
February 22, 2024 | -18.01% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-63.16%
Minimum
Mar 18 2020
82.79%
Maximum
Mar 18 2021
-18.31%
Average
-19.16%
Median
Mar 02 2023
1 Year Total Returns (Daily) Benchmarks
Sarepta Therapeutics Inc | 5.57% |
Amgen Inc | 21.94% |
Gilead Sciences Inc | -15.58% |
AbbVie Inc | 10.38% |
Bristol-Myers Squibb Co | -33.07% |